Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Offering SPR-BLI Services - Proteins provided for free!
Get your ComboX free sample to test now!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
|---|---|---|---|---|---|
| IL7-H52H7 | Human | Human IL-7 R alpha / CD127 Protein, His Tag |  |
|
|
| IL7-H82F9 | Human | Biotinylated Human IL-7 R alpha / CD127 Protein, Fc,Avitag™ |  |
|
|
| ILR-M5253 | Mouse | Mouse IL-7 R alpha / CD127 Protein, Fc Tag |  |
|
|
| ILA-H525a | Human | Human IL-7 R alpha / CD127 Protein, Fc Tag |  |
|
|
| IL7-H5258 | Human | Human IL-7 R alpha / CD127 Protein, Mouse IgG2a Fc Tag |  |
|
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Interleukin-7 (Revimmune SAS) | rhIL-7; CYT-107; CYT-99-007 | Phase 2 Clinical | Cytheris | Urinary Bladder Neoplasms; Catheter-Related Infections; Neuroectodermal Tumors, Primitive, Peripheral; Melanoma; T-Lymphocytopenia, Idiopathic CD4-Positive; Leukemia, Myeloid, Acute; Urologic Neoplasms; Ureteral Neoplasms; Hepatitis C; Lymphopenia; Urethral Neoplasms; Prostatic Neoplasms; Sarcoma; Neuroblastoma; Shock, Septic; Prostatic Neoplasms, Castration-Resistant; Carcinoma, Transitional Cell; Sepsis; Myeloproliferative Disorders; Coronavirus Disease 2019 (COVID-19); Mycobacterium Infections, Nontuberculous; Myelodysplastic Syndromes; Carcinoma, Renal Cell; Hepatitis B, Chronic; Rhabdoid Tumor; Leukemia, Myelogenous, Chronic; Kidney Neoplasms; HIV Infections | Details |
| MDK-703 | MDK-703 | Phase 2 Clinical | Medikine Inc | Solid tumours | Details |
| GSK-3888130-B | GSK-3888130-B; GSK3888130B | Phase 1 Clinical | Glaxosmithkline Plc | Multiple Sclerosis | Details |
| PF-06342674 | RN-168; PF-6342674; PF-06342674; ZB-168 | Phase 1 Clinical | Pfizer Inc | Diabetes Mellitus, Type 1; Multiple Sclerosis | Details |
| Efineptakin alfa | NT-I7; GX-I7; TJ-107 | Phase 2 Clinical | Genexine Inc | Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Sarcoma, Kaposi; Melanoma; Leukoencephalopathy, Progressive Multifocal; Carcinoma, Squamous Cell; Lymphopenia; Colorectal Neoplasms; Breast Neoplasms; Urinary Bladder Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Triple Negative Breast Neoplasms; Papillomavirus Infections; Glioblastoma; Coronavirus Disease 2019 (COVID-19); Squamous Cell Carcinoma of Head and Neck; Carcinoma, Merkel Cell; Esophageal Neoplasms; HIV Infections; Ovarian Neoplasms | Details |
| BNT-152 | BNT-152 | Phase 1 Clinical | Biontech Se | Solid tumours | Details |
| Lusvertikimab | OSE-127; S-95011; Effi-7; OSE-217 | Phase 2 Clinical | Effimune | Sjogren's Syndrome; Colitis, Ulcerative | Details |
| ASP-9801 | ASP-9801 | Phase 1 Clinical | Astellas Pharma Inc | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
This web search service is supported by Google Inc.
A-Z
